249 related articles for article (PubMed ID: 31639788)
21. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
22. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
23. Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma - a systematic review.
Sharma AN; Foulad DP; Doan L; Lee PK; Atanaskova Mesinkovska N
J Dermatolog Treat; 2021 Mar; 32(2):157-163. PubMed ID: 31696746
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatments for lentigo maligna: a review.
McLeod M; Choudhary S; Giannakakis G; Nouri K
Dermatol Surg; 2011 Sep; 37(9):1210-28. PubMed ID: 21631635
[TBL] [Abstract][Full Text] [Related]
25. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
Ren M; Kong YY; Shen XX; Cai X; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
[No Abstract] [Full Text] [Related]
26. Treatment of lentigo maligna with imiquimod 5% cream.
Hopson B; Richey D; Sajben FP
J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
[TBL] [Abstract][Full Text] [Related]
27. [Lentigo maligna: a special melanoma].
Le Gal FA; Toutous-Trellu L; Kaya G; Salomon D
Rev Med Suisse; 2011 Apr; 7(289):765-6, 768-71. PubMed ID: 21568099
[TBL] [Abstract][Full Text] [Related]
28. Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
Navarrete-Dechent C; Cordova M; Aleissa S; Liopyris K; Dusza SW; Kose K; Busam KJ; Hollman T; Lezcano C; Pulitzer M; Chen CJ; Lee EH; Rossi AM; Nehal KS
J Am Acad Dermatol; 2023 Feb; 88(2):371-379. PubMed ID: 31812621
[TBL] [Abstract][Full Text] [Related]
29. Lentigo maligna: current concepts in diagnosis and management.
Walling HW
G Ital Dermatol Venereol; 2009 Apr; 144(2):149-55. PubMed ID: 19357622
[TBL] [Abstract][Full Text] [Related]
30. Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.
Hibler BP; Connolly KL; Lee EH; Rossi AM; Nehal KS
Lasers Surg Med; 2017 Nov; 49(9):819-826. PubMed ID: 28555933
[TBL] [Abstract][Full Text] [Related]
31. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
[TBL] [Abstract][Full Text] [Related]
32. In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections.
Tannous ZS; Mihm MC; Flotte TJ; González S
J Am Acad Dermatol; 2002 Feb; 46(2):260-3. PubMed ID: 11807439
[TBL] [Abstract][Full Text] [Related]
33. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
34. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
[TBL] [Abstract][Full Text] [Related]
35. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Bartenjev MS; Isaković-Vidović S; Bartenjev I
Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
[TBL] [Abstract][Full Text] [Related]
36. Lentigo maligna.
Samaniego E; Redondo P
Actas Dermosifiliogr; 2013 Nov; 104(9):757-75. PubMed ID: 22857817
[TBL] [Abstract][Full Text] [Related]
37. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines.
Agarwal-Antal N; Bowen GM; Gerwels JW
J Am Acad Dermatol; 2002 Nov; 47(5):743-8. PubMed ID: 12399768
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
39. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
40. Lentigo maligna: a review.
Karponis D; Stratigos IA; Joshy J; Craig PJ; Mistry K; van Bodegraven B; Venables ZC; Levell NJ
Clin Exp Dermatol; 2024 Feb; 49(3):218-225. PubMed ID: 37966718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
